Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antenatal Myo-inositol Supplementation in Pre-existing Diabetes — Stella

Home/Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)/Antenatal Myo-inositol Supplementation in Pre-existing Diabetes

View on ClinicalTrials.gov

Recruiting

Back to Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM) trials

Antenatal Myo-inositol Supplementation in Pre-existing Diabetes

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Singapore

National University Hospital, Singapore, Singapore

Key details

Sponsor

National University Hospital, Singapore

Collaborators

National University of Singapore

Enrollment target

~182 participants

Started

December 2025

Primary completion

August 2028

Age range

21 Years – 45 Years

Sex

Female only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.